Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

BioVirtus (Poland) | Researchclopedia

Back to institutions

BioVirtus (Poland)

Nadarzyncompany

9

Works

223

Citations

7

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research PARP inhibition in cancer therapy

Top Researchers

Krzysztof Jeziorski University of Information Technology and Management in Rzeszow

68 works2,230 citationsh-index: 14

Recent Research

Extended Units of Meaning—Lexical Items

Łukasz Grabowski,Tadeusz Piotrowski

20260 citations

Syntax, Semantics, Linguistic Variation

Lymphoma Diagnosis and Treatment

Anesthesia and Sedative Agents

Prostate Cancer Treatment and Research

Ovarian cancer diagnosis and treatment

Immunotherapy and Immune Responses

Testicular diseases and treatments

Language, Metaphor, and Cognition

Pain Management and Opioid Use

Monika Tomaszewska‐Kiecana University of Gdańsk

35 works774 citationsh-index: 14

Katarzyna Jarus‐Dziedzic Institute of Physiology and Pathology of Hearing

24 works172 citationsh-index: 7

Tadeusz Piotrowski BioVirtus (Poland)

39 works78 citationsh-index: 5

Monika Tomaszewska-Kiecana Çevre, Şehircilik ve İklim Değişikliği Bakanlığı

6 works44 citationsh-index: 4

Andrzej Pelisiak BioVirtus (Poland)

51 works29 citationsh-index: 3

Andrzej Pelisiak (Review) Lubomir Šebela and Antonin Přichystal, Silicite daggers in the territory of the Czech and Slovak Republics. Spisy Archeologického ústavu AV ČR Brno, 78. Brno 2024: Czech Academy of Sciences, Institute of Archaeology. ISSN 1804-13

Andrzej Pelisiak

20250 citations

A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)

Nehal J. Lakhani,Rasha Cosman,et al.

202421 citations

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

Jason J. Luke,Manish R. Patel,et al.

2023116 citations

A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors

Mingxiang Liao,Krzysztof Jeziorski,et al.

202110 citations

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

Nikolay Grechko,Viera Skarbová,et al.

202117 citations